SCHEMBL2265862

SCHEMBL2265862

CC(C)Oc1ccc2[nH]cc(S(=O)(=O)c3cccc(NC4CCN(C)CC4)c3)c2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 8/20 0.41
MAPT P10636 1/20 0.40
FLT3 P36888 2/20 0.37
ROCK2 O75116 1/20 0.37
HDAC3 O15379 1/20 0.36
HDAC4 P56524 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC7 Q8WUI4 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC10 Q969S8 1/20 0.36
HDAC11 Q96DB2 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
HDAC9 Q9UKV0 1/20 0.36
HDAC5 Q9UQL6 1/20 0.36
JAK2 O60674 1/20 0.36
BRD4 O60885 1/20 0.36
PDE5A O76074 1/20 0.36
TP53 P04637 1/20 0.36
HTR1A P08908 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14354294 0.90 MAPT (0.52) HTR6MAPTFLT3TP53HTR1A
SCHEMBL2278202 0.85 MAPT (0.44) HTR6MAPTTP53
SCHEMBL2270255 0.84 MAPT (0.41) HTR6MAPTTP53
SCHEMBL16986602 0.84 HTR6 (0.47) HTR6JAK2BRD4HTR1AHTR1D
SCHEMBL2278320 0.84 HTR6 (0.48) HTR6JAK2BRD4PDE5A
SCHEMBL2222544 0.84 CYP3A4 (0.46) HTR6MAPTTP53
Hydrochloric Acid SCHEMBL2268842 0.84 HTR6 (0.46) HTR6JAK2BRD4HTR1AHTR1D
SCHEMBL4630008 0.82 HTR6 (0.42) HTR6FLT3ROCK2PDE5ACCR6
SCHEMBL2222129 0.82 HTR6 (0.46) HTR6MAPTJAK2BRD4
SCHEMBL16986603 0.79 POLB (0.44) HTR6JAK2BRD4HTR1AHTR1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2521714-A1 SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS Suven Life Sciences Limited (IN) 2012-11-14 EP claimed
WO-2011083487-A1 SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS SUVEN LIFE SCIENCES LIMITED (IN) 2011-07-14 WO claimed
US-9018231-B2 Sulfone compounds as 5-HT6 receptor ligands SUVEN LIFE SCIENCES LIMITED (IN) 2015-04-28 US disclosed
US-20130005709-A1 SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS SUVEN LIFE SCIENCES LIMITED (IN) 2013-01-03 US disclosed
EP-2521714-A1 SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS Suven Life Sciences Limited (IN) 2012-11-14 EP disclosed
WO-2011083487-A1 SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS SUVEN LIFE SCIENCES LIMITED (IN) 2011-07-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130005709-A1 SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS HTR6, HTR5A, HTR1A HTR6 1/4885MAPT 509/4885FLT3 1671/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.